# Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes

> **NCT00394407** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 130 (actual)

## Conditions studied

- Diabetes
- Hyperglycemia

## Interventions

- **DRUG:** sliding scale regular insulin
- **DRUG:** glargine basal insulin and glulisine prandial insulin

## Key facts

- **NCT ID:** NCT00394407
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2013-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394407, "Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT00394407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*